AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle
Summary
Featured at this year’s meeting on early cancer research were results from an immunotherapy Merck acquired in 2024 and several targeted medicines for lung tum...
Description
Featured at this year’s meeting on early cancer research were results from an immunotherapy Merck acquired in 2024 and several targeted medicines for lung tum...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source